Colgate-Palmolive posted a Q4 net loss of $37M as goodwill and intangible asset impairments impacted GAAP earnings. Revenue rose 5.8% to $5.23B, and non-GAAP EPS increased modestly to $0.95.

Colgate-Palmolive delivered a 2% increase in net sales and maintained flat adjusted EPS, as lower private label pet sales and margin contraction weighed on performance. Organic growth was limited but the company reaffirmed its full-year guidance.

Colgate-Palmolive posted a 1.0% increase in net sales and continued leadership in oral care with strong global market share in both toothpaste and toothbrushes. Net income rose slightly, and adjusted EPS was up marginally. Organic sales grew despite headwinds in pet nutrition from lower private label sales.

Colgate-Palmolive posted a solid Q1 with EPS growth driven by operational discipline and strong brand execution, offsetting foreign exchange headwinds and soft volumes in some regions.

Colgate-Palmolive reported a 4.9% increase in net sales and a 9.0% increase in organic sales for Q2 2024. GAAP EPS increased by 48% to $0.89, and the GAAP gross profit margin increased by 280 basis points to 60.6%. The company has updated its financial guidance for the full year 2024.

Colgate-Palmolive reported a 6.2% increase in net sales and a 9.8% increase in organic sales for Q1 2024. GAAP EPS increased by 84% to $0.83, while Base Business EPS increased by 18% to $0.86. The company raised its full-year guidance for net sales and organic sales growth.

Colgate-Palmolive reported strong Q4 2023 results, with a 7.0% increase in both net and organic sales. The company saw improvements to organic volume performance, gross and operating profit margin expansion, and double-digit earnings per share growth. For the full year, net and organic sales grew by 8.5%.

Colgate-Palmolive reported strong Q3 2023 results with a 10.5% increase in net sales and a 16% increase in EPS. Organic sales grew by 9.0%, with volume improving sequentially. The company raised its full-year financial guidance, expecting continued growth and profitability.

Colgate-Palmolive reported a strong second quarter in 2023, with net sales increasing by 7.5% and organic sales growing by 8.0%. The company saw growth in every division and in all four categories. Diluted EPS was $0.60, a 17% decrease, while base business EPS increased 7% to $0.77. The company updated its full year 2023 financial guidance.

Colgate-Palmolive reported an 8.5% increase in net sales and a 10.0% increase in organic sales for Q1 2023. GAAP EPS decreased by 32% to $0.45, while Base Business EPS declined by 1% to $0.73. The company's strategy to accelerate growth is showing positive momentum, with improvements in net and organic sales growth, gross profit margin, advertising spending, operating profit, and free cash flow.

Colgate-Palmolive reported a net sales increase of 5.0% and organic sales growth of 8.5% in Q4 2022. EPS declined 94% to $0.01, driven by goodwill and intangible assets impairment charges related to the Filorga skin health business. On a Base Business basis, EPS declined 3% to $0.77.

Colgate-Palmolive reported a slight increase in net sales, driven by organic sales growth across all divisions and categories. However, EPS declined due to negative foreign exchange impacts and higher raw material and logistics costs.

Colgate-Palmolive reported a 5.5% increase in net sales and a 9.0% increase in organic sales for Q2 2022, with growth across all divisions and categories. However, GAAP EPS declined by 13% to $0.72 due to increased raw material, packaging, and logistics costs. The company raised its organic sales growth guidance for the full year to 5% to 7%.

Colgate-Palmolive reported a mixed performance for Q1 2022. Net sales increased by 1.5%, and organic sales grew by 4.0%, driven by higher pricing. However, EPS declined by 18% on a GAAP basis and 8% on a non-GAAP basis due to significant increases in raw material and logistics costs.

Colgate-Palmolive announced its Q4 and full year 2021 results, with Q4 net sales increasing by 2.0% and organic sales increasing by 3.0%. EPS declined by 76% to $0.18, influenced by goodwill and intangible asset impairment charges related to the Filorga skin health business. The company's leadership in toothpaste and manual toothbrushes continued, with global market shares of 39.4% and 30.9% respectively.

Colgate-Palmolive reported a 6.5% increase in net sales and a 4.5% increase in organic sales for Q3 2021. EPS decreased by 7% on a GAAP basis to $0.75, but increased by 3% on a Base Business basis to $0.81. The company confirmed its full-year financial guidance.

Colgate-Palmolive reported strong second-quarter results with net sales increasing by 9.5% and EPS growing by 12%. The company's organic sales grew by 5.0%, marking the tenth consecutive quarter of growth in or above the targeted range. Despite facing raw material and logistics cost headwinds, the company delivered increased operating profit, net income, and earnings per share on a Base Business basis.

Colgate-Palmolive Company reported a 6.0% increase in net sales and a 5.0% increase in organic sales for the first quarter of 2021. EPS declined 4% on a GAAP basis but grew 7% on a base business basis. The company reiterated its full year 2021 financial guidance.

Colgate-Palmolive reported strong Q4 2020 results with net sales increasing by 7.5% and organic sales increasing by 8.5%. GAAP EPS remained even at $0.75, while Base Business EPS grew by 5% to $0.77. The company's strong gross profit performance funded a significant increase in advertising, contributing to increases in operating profit, net income, and earnings per share on a base business basis.

Colgate-Palmolive Company reported strong Q3 2020 results, with net sales increasing by 5.5% and organic sales growing by 7.5%. The company saw double-digit increases in operating profit, net income, and earnings per share. Premium innovation and eCommerce strength, particularly in the Hill's business, drove growth across all product categories.

Colgate-Palmolive reported a 1.0% increase in net sales and a 5.5% increase in organic sales for Q2 2020. GAAP EPS grew by 9% to $0.74. The company experienced strong growth in North America and Hill's, but faced challenges due to foreign exchange impacts. Due to continued uncertainty, the company has decided not to reinstate financial guidance for 2020 at this time.

Colgate-Palmolive reported a net sales increase of 5.5% and organic sales increase of 7.5% for the first quarter of 2020. GAAP EPS grew by 28% to $0.83, while base business EPS grew by 12% to $0.75. The company withdrew its 2020 financial guidance due to the uncertainty surrounding the business impacts from COVID-19.

Colgate-Palmolive reported a 5.5% increase in worldwide Net sales, reaching $4,015 million. Net income was $643 million, with diluted earnings per share at $0.75. The company's organic sales grew by 5.0%, driven by volume and pricing increases, with a contribution from the Filorga acquisition.